Search

Current Treatment Concepts of CML

Journal: Current Cancer Drug Targets
Volume: 11 Issue: 1 Year: 2011 Page: 31-43
Author(s): A. A. Leitner, A. Hochhaus, M. C. Muller

Effects of BCR-ABL Inhibitors on Anti-Tumor Immunity

Journal: Current Medicinal Chemistry
Volume: 18 Issue: 3 Year: 2011 Page: 5174-5184
Author(s): M. Krusch, H. R. Salih

Journal: Current Cancer Drug Targets
Volume: 11 Issue: 1 Year: 2011 Page: 3-19
Author(s): H. Rumpold, G. Webersinke

Omacetaxine as an Anticancer Therapeutic: What is Old is New Again

Journal: Current Pharmaceutical Design
Volume: 17 Issue: 1 Year: 2011 Page: 59-64
Author(s): Meir Wetzler, David Segal

BCR-ABL Inhibitors in Chronic Myeloid Leukemia: Process Chemistry and Biochemical Profile

Journal: Current Medicinal Chemistry
Volume: 18 Issue: 1 Year: 2011 Page: 2943-2959
Author(s): F. Leonetti, A. Stefanachi, O. Nicolotti, M. Catto, L. Pisani, S. Cellamare, A. Carotti

Dasatinib in the Treatment of Chronic Myeloid Leukemia

Journal: Current Signal Transduction Therapy
Volume: 6 Issue: 1 Year: 2011 Page: 99-105
Author(s): Joanna Gora-Tybor, Tadeusz Robak

Interferon alpha for Treatment of Chronic Myeloid Leukemia

Journal: Current Drug Targets
Volume: 12 Issue: 3 Year: 2011 Page: 420-428
Author(s): Bengt Simonsson, Henrik Hjorth-Hansen, Ole Weis Bjerrum, Kimmo Porkka

Dasatinib: An Anti-Tumour Agent via Src Inhibition

Journal: Current Drug Targets
Volume: 12 Issue: 4 Year: 2011 Page: 563-578
Author(s): Antonio Gnoni, Ilaria Marech, Nicola Silvestris, Angelo Vacca, Vito Lorusso

Immunotherapy for Myeloproliferative Neoplasms (MPN)

Journal: Current Cancer Drug Targets
Volume: 11 Issue: 1 Year: 2011 Page: 72-84
Author(s): Susanne Hofmann, Anna Babiak, Jochen Greiner

Targeting of Leukemia-Initiating Cells to Develop Curative Drug Therapies: Straightforward but Nontrivial Concept

Journal: Current Cancer Drug Targets
Volume: 11 Issue: 1 Year: 2011 Page: 56-71
Author(s): P. Valent